UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
(Mark One)
[ X ] Quarterly report pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 for the quarterly period ended December 28, 1996 or
[ ] Transition report pursuant to section 13 or 15(d)
of the Securities Exchange Act of 1934 for the transition period from to
.
Commission File Number 0-18548
Xilinx, Inc.
(Exact name of registrant as specified in its
charter)
Delaware 77-0188631
(State or other jurisdiction of (I.R.S. Employer Identification
incorporation or organization) Number)
2100 Logic Drive, San Jose, California 95124
(Address of principal executive offices) (Zip Code)
(408) 559-7778
(Registrant's telephone number, including area
code)
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such requirements for the past 90 days.
YES X NO
Class Shares Outstanding at December 28, 1996
Common Stock, $.01 par value 73,043,000
XILINX, INC.
CONSOLIDATED CONDENSED STATEMENT OF INCOME
(in thousands except per share amounts)
Three Months Ended Nine Months Ended
Dec. 28, | Dec. 30, | Dec. 28 | Dec. 30, | |
1996 | 1995 | 1996 | 1995 | |
Net revenues | $ 135,587 | $ 144,123 | $ 416,366 | $ 411,095 |
Costs and expenses: | ||||
Cost of revenues | 52,156 | 51,672 | 156,139 | 151,792 |
Write-off of discontinued product family | - | - | 5,000 | - |
Research and development | 17,698 | 16,228 | 52,283 | 47,733 |
Marketing, general and administrative | 28,830 | 26,905 | 87,087 | 79,142 |
Non-recurring charges | - | - | - | 19,366 |
Operating costs and expenses | 98,684 | 94,805 | 300,509 | 298,033 |
Operating income | 36,903 | 49,318 | 115,857 | 113,062 |
Interest and other income | 5,353 | 3,288 | 15,121 | 6,546 |
Interest expense | (3,407) | (1,913) | (10,320) | (2,076) |
Income before provision for taxes on income | 38,849 | 50,693 | 120,658 | 117,532 |
Provision for taxes on income | 12,626 | 18,503 | 40,725 | 49,968 |
Net income | $ 26,223 | $ 32,190 | $ 79,933 | $ 67,564 |
Net income per share | $ 0.33 | $ 0.41 | $ 1.01 | $ 0.86 |
Weighted average common and common | ||||
equivalent shares used in computing | ||||
per share amounts | 79,791 | 79,106 | 79,371 | 78,732 |
(See accompanying Notes to Consolidated Condensed Financial
Statements.)
XILINX, INC.
CONSOLIDATED CONDENSED BALANCE SHEET
(in thousands except per share amounts)
Dec. 28, |
March 30, |
|
1996 |
1996 |
|
ASSETS | ||
Current assets: | ||
Cash and cash equivalents | $ 155,003 | $ 110,893 |
Short-term investments | 235,099 | 267,068 |
Accounts receivable, net | 68,549 | 79,528 |
Inventories | 70,181 | 39,238 |
Deferred income taxes and other current assets | 35,059 | 41,979 |
Total current assets | 563,891 | 538,706 |
Property, plant and equipment, at cost | 150,338 | 128,283 |
Accumulated depreciation and amortization | (61,843) | (45,645) |
Net property, plant and equipment | 88,495 | 82,638 |
Restricted investments | 36,730 | 36,212 |
Investment in joint venture | 35,404 | 34,316 |
Advances for wafer purchases | 60,000 | - |
Developed technology and other assets | 26,291 | 29,008 |
$ 810,811 | $ 720,880 | |
LIABILITIES AND STOCKHOLDERS' EQUITY | ||
Current liabilities: | ||
Accounts payable, accrued liabilities, income taxes | ||
payable and current obligations under capital leases | $ 71,333 | $ 65,068 |
Deferred income on shipments to distributors | 29,347 | 37,568 |
Total current liabilities | 100,680 | 102,636 |
Long-term debt | 250,000 | 250,000 |
Stockholders' equity: | ||
Preferred stock, $.01 par value | - | - |
Common stock, $.01 par value | 730 | 719 |
Additional paid-in capital | 112,181 | 100,020 |
Treasury stock | (218) | - |
Retained earnings | 347,438 | 267,505 |
Total stockholders' equity | 460,131 | 368,244 |
$ 810,811 | $ 720,880 | |
(See accompanying Notes to Consolidated Condensed Financial
Statements.)
XILINX, INC.
CONSOLIDATED CONDENSED STATEMENT OF CASH FLOWS
Increase (decrease) in cash and cash equivalents
(in thousands)
Nine Months Ended
Dec. 28, |
Dec. 30, |
|
1996 |
1995 |
|
Cash flows from operating activities: | ||
Net income | $ 79,933 | $ 67,564 |
Adjustments to reconcile net income to net cash | ||
provided by operating activities: | ||
Write-off of in-process technology | - | 19,366 |
Depreciation and amortization | 20,195 | 15,981 |
Undistributed earnings of joint venture | (938) | - |
Changes in assets and liabilities net of effects of NeoCAD acquisition: | ||
Accounts receivable | 10,979 | (26,175) |
Inventories, including the impact of receipts against advances
for wafer purchases |
(21,908) |
20,206 |
Deferred income taxes and other | 1,607 | (1,436) |
Accounts payable, accrued liabilities and income taxes payable | 7,044 | 1,916 |
Deferred income on shipments to distributors | (8,221) | 10,614 |
Total adjustments net of effects of NeoCAD acquisition | 8,758 | 40,472 |
Net cash provided by operating activities | 88,691 | 108,036 |
Cash flows from investing activities: | ||
Purchases of short-term available-for-sale investments | (209,111) | (268,679) |
Proceeds from sale or maturity of short-term available-for-sale investments | 240,650 | 69,620 |
Purchases of restricted held-to-maturity investments | (36,097) | (59,929) |
Proceeds from sale or maturity of restricted held-to-maturity investments | 36,092 | 36,384 |
Advances for wafer purchases | (60,000) | - |
Acquisition of NeoCAD, net of cash acquired | - | (33,412) |
Property, plant and equipment | (22,300) | (43,155) |
Net cash used in investing activities | (50,766) | (299,171) |
Cash flows from financing activities: | ||
Net proceeds from issuance of long-term debt | - | 244,197 |
Acquisition of treasury stock | (15,729) | - |
Principal payments on capital lease obligations | (779) | (1,168) |
Proceeds from issuance of common stock | 22,693 | 11,700 |
Net cash provided by financing activities | 6,185 | 254,729 |
Net increase in cash and cash equivalents | 44,110 | 63,594 |
Cash and cash equivalents at beginning of period | 110,893 | 56,703 |
Cash and cash equivalents at end of period | $ 155,003 | $ 120,297 |
Schedule of non-cash transactions: | ||
Tax benefit from stock options | $ 5,484 | $ 5,459 |
Issuance of treasury stock under employee stock plans | 15,511 | 7,369 |
Receipts against advances for wafer purchases | 9,035 | 23,220 |
Supplemental disclosures of cash flow information: | ||
Interest paid | $ 12,561 | $ 192 |
Income taxes paid | 26,416 | 53,800 |
(See accompanying Notes to Consolidated Condensed Financial
Statements.)
XILINX, INC.
NOTES TO CONSOLIDATED CONDENSED FINANCIAL STATEMENTS
1. The accompanying interim consolidated financial statements have been
prepared in conformity with generally accepted accounting principles and
should be read in conjunction with the Xilinx, Inc. consolidated financial
statements for the year ended March 30, 1996. The balance sheet at March
30, 1996 is derived from audited financial statements. The interim financial
statements are unaudited but reflect all adjustments which are in the opinion
of management of a normal, recurring nature necessary to present a fair
statement of results for the interim periods presented. The results for
the nine month period ended December 28, 1996 are not necessarily indicative
of the results that may be expected for the year ending March 29, 1997.
2. Inventories are stated at the lower of cost (first-in, first-out)
or market (estimated net realizable value). Inventories at December 28,
1996 and March 30, 1996 are as follows:
December 28, |
March 30, |
|
1996 |
1996 |
|
Raw materials | $ 4,929 | $ 5,886 |
Work-in-process | 50,581 | 21,927 |
Finished goods | 14,671 | 11,425 |
$ 70,181 | $ 39,238 |
3. On May 17, 1996, the Company signed an agreement with Seiko Epson
Corporation (Seiko), a primary wafer supplier. The agreement provides for
total payments to Seiko of $300 million to be used in the construction
of a wafer fabrication facility in Japan which will provide access to eight-inch,
sub-micron wafers. Of the total payments, $200 million represents an advance
payment for future wafer deliveries. In conjunction with the agreement,
$30 million installments were paid in May 1996 and November 1996 and additional
installments of $30 million are scheduled for May 1, 1997, November 1,
1997 and February 1, 1998 or upon the start of mass production, whichever
is later. The final installment for the advance payment of $50 million
is due on or after the later of April 1, 1998 or the date the outstanding
balance of the advance payment is less than $125 million. As a result,
the maximum outstanding amount of the advance payment at any time will
be $175 million. Repayment of this advance will be in the form of wafer
deliveries using U.S. dollar denominated pricing. Specific wafer pricing
will be based upon the prices of similar wafers manufactured by other,
specifically identified, leading-edge foundry suppliers. The advance payment
provision also provides for interest to be paid to the Company in the form
of free wafers. In addition to the advance payments, the Company will provide
further funding to Seiko in the amount of $100 million. This additional
funding will be paid after the final installment of the $200 million advance,
and the form of the additional funding will be negotiated at that time.
4. The Company discontinued the XC8100 family of one-time programmable
antifuse devices. As a result, the Company recorded a pretax charge against
earnings of $5 million. This charge primarily related to the write-off
of inventories held by Xilinx and its distributors and for termination
charges related to purchase commitments to foundry partners for work in
process wafers which had not completed the manufacturing process.
5. On September 16, 1996, the Company's Board of Directors authorized
a stock repurchase program whereby up to 2 million shares of the Company's
common stock may be purchased in the open market from time to time as market
and business conditions warrant. The Company plans to use shares repurchased
to meet the stock requirements of the Company's Stock Option and Employee
Qualified Stock Purchase plans. During the quarter ended December 28, 1996,
the Company repurchased 490,000 shares of common stock for $15.7 million,
of which 483,000 shares were reissued during the period in response to
stock option exercises and stock purchase plan requirements. As of January
31, 1997, an additional 252,500 shares of common stock have been repurchased
for $10.3 million.
6. The Company is currently involved in patent litigation with Altera
Corporation (see Part II, Item 1, Legal Proceedings). Due to the uncertain
nature of the litigation with Altera and because the lawsuits are still
in the pre-trial stage, the ultimate outcome of these matters cannot be
determined at this time. Management believes that it has meritorious defenses
to such claims and is defending them vigorously, and has not recorded a
provision for the ultimate outcome of these matters in its financial statements.
The foregoing is a forward looking statement based on information presently
known to management. Due to the uncertain nature of the litigation with
Altera and because the lawsuits are still in the pre-trial stage, actual
results could differ materially.
XILINX, INC.
MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION
AND RESULTS OF OPERATIONS
The statements in this Management's Discussion and Analysis that are
forward looking involve numerous risks and uncertainties and are based
on current expectations. Actual results may differ materially. Such risks
and uncertainties are detailed below.
Results of operations - Third quarter and first
nine months of fiscal 1997 compared to the third quarter and first nine
months of fiscal 1996
Revenues
Revenues for the third quarter of fiscal 1997 of $135.6
million represented a $8.5 million, or 5.9%, decrease from the corresponding
period of fiscal 1996. Revenues for the first nine months of fiscal 1997
were $416.4 million, an increase of 1.3% from the corresponding period
of 1996. Revenues for the third quarter of fiscal 1997, as compared to
the comparable prior year period, were adversely impacted by the general
slowdown in the semiconductor industry, customer efforts to reduce inventory
levels, customer programs which have not ramped up as quickly as expected
and price reductions in response to a competitive pricing environment.
The revenue decrease during the third quarter of fiscal 1997 was primarily
attributable to decreases in revenues relating to the non-proprietary members
of the XC3000 family, the XC3100 family and the XC4000 family partially
offset by increases in revenues relating to the XC5200 family. Relative
to the prior year quarter, revenues for the non-proprietary members of
the XC3000 family decreased by $9.7 million, or 45.4%, revenues for the
XC3100 family decreased by $2.3 million, or 14.8% and revenues for the
XC4000 family decreased by $4 million, or 6.3% offset by an $8.5 million
increase in revenue for the XC5200 family, up from $2.8 million in the
prior year. Revenues from two of the Company's newer product families,
the XC4000EX and the XC9500, contributed more than $2 million in revenues
during the third quarter of fiscal 1997. Revenues for the Company's first
generation FPGA products, which includes the XC2000, XC3000 and XC3100
families, represented 32.5% of aggregate component revenues in the third
quarter of fiscal 1997 and decreased 20.3% relative to the results of the
comparable quarter of the prior fiscal year. Revenues for the Company's
second generation FPGA products, which includes the XC4000, XC4000EX and
XC5200 families as well as the recently introduced XC6200 family, represented
54.9% of aggregate component revenues and exceeded the revenues of the
comparable quarter of the prior year by 8.6%. The increase in revenues
relating to the second generation of products is primarily a function of
increasing demand for the functionality, performance and pricing provided
by these product families. The other products generation, consisting primarily
of the CPLD families, the Hardwire product and serial proms, represented
12.6% of aggregate component revenues in the third quarter of fiscal 1997
and decreased 10.0% relative to the results of the comparable quarter of
the prior year. Proprietary products constituted 91.4% of revenues for
the third quarter of fiscal 1997, as compared to 85.2% in the comparable
quarter last year. Software revenues represented approximately 3% of total
revenues for all periods presented.
Independent semiconductor industry analyst projections
indicated that the overall semiconductor industry would experience lower
growth rates for 1996 than those experienced over the last few years. See
"Factors Affecting Future Operating Results" for discussion relating
to potential impact of semiconductor industry conditions on the Company's
business.
The Company expects total revenues for fiscal 1997 to
approximate fiscal 1996 revenues. The Company believes that the conditions
that led to slow sequential quarterly revenue growth or declining sequential
quarterly revenue growth over the last five fiscal quarters, are still
present. The Company also realizes that a prolonged slowdown in the overall
semiconductor industry would detrimentally impact Xilinx. Based on current
inventory levels and wafer capacity availability, the Company is generally
able to deliver products to customers within fairly short lead times. As
a result, many of the Company's customers are placing orders for near-term
delivery and providing the Company relatively limited visibility to demand
for products in the intermediate to long-term range. In this environment,
the level of customer orders for a given quarter is difficult to predict.
While the Company currently projects the revenue growth rate for the last
quarter of fiscal 1997 to be in the low single-digit range, no assurance
can be given that this will be the case.
The preceding two paragraphs contain forward-looking statements
which involve risks and uncertainties. The Company's actual results could
differ materially from those anticipated in these forward-looking statements
as a result of certain factors including those set forth in "Factors
Affecting Future Operating Results", "Dependence on New Products"
and those described above.
Gross Margin
Cost of revenues were $52.2 million, or 38.5% of revenues,
and $156.1 million, excluding the impact of the $5 million non-recurring
write-off relating to the XC8100 product family in the second quarter of
fiscal 1997, or 37.5% of revenues, for the third quarter and first nine
months of fiscal 1997, respectively. Costs of revenues for the comparable
periods of fiscal 1996 were $51.7 million, or 35.9% of revenues, and $151.8
million, or 36.9% of revenues, respectively. The increase in the cost of
revenues as a percentage of revenues during the third quarter of fiscal
1997 over the comparable quarter of the prior year was primarily attributable
to price reductions and increased inventory reserves relating to an expanded
level of inventory partially offset by favorable impact of lower wafer
costs (reflecting the strengthened U.S. dollar exchange rate against the
yen) and improved yields. The Company was able to partially offset the
negative impact of ongoing price reductions for its existing products with
increased volumes of newer, proprietary, higher margin products although
not to the extent the Company has done so in prior periods. The Company
recognizes that ongoing price reductions for its integrated circuits are
a significant element in expanding the market for its products. Company
management believes that the gross margins of up to 65.7% of revenues (achieved
during the fourth quarter of fiscal 1996) were neither sustainable nor
desirable in the future. Rather, gross margins closer to the historical
range of 60% to 62% of revenues, including the 61.5% gross margin realized
in the third quarter of fiscal 1997, are considered more appropriate for
expanding market share while realizing acceptable returns, although there
can be no assurance that future gross margins will be in this range.
Research and Development
Research and development expenditures were $17.7 million
for the third quarter and $52.3 million for the first nine months of fiscal
1997, or 13.1% and 12.6% of revenues respectively, compared to $16.2 million
and $47.7 million, or 11.3% and 11.6% of revenues, respectively, in the
comparable fiscal 1996 periods. Research and development expenditures for
the third quarter of fiscal 1997 increased as a percentage of revenues
as a function of the decrease in revenues. Research and development expenses
increased in the third quarter of fiscal 1997 over the comparable fiscal
1996 period as a result of increased headcount, increased purchases of
engineering wafers and higher depreciation for design software. The 9.5%
increase in research and development expenditures for the first nine months
of fiscal 1997 as compared to the comparable fiscal 1996 period resulted
primarily from increased headcount, higher engineering wafer purchases,
and increased facility and support costs associated with an expanded scope
of operations. The Company remains committed to a significant level of
research and development effort in order to continue to compete aggressively
in the programmable logic marketplace.
Non-recurring Charges
During the first nine months of fiscal 1996, the Company
incurred a $19.4 million non-recurring write-off of in-process technology
relating to the acquisition of NeoCAD, Inc.
Marketing, General and Administrative
Marketing, general and administrative expenses were $28.8
million for the third quarter and $87.1 million for the first nine months
of fiscal 1997, or 21.3% and 20.9% of revenues, respectively, compared
to $26.9 million and $79.1 million, or 18.7% and 19.3% of revenues, respectively,
in the comparable fiscal 1996 periods. These expenses have increased in
amount primarily as a result of increased headcount as well as increased
marketing and sales related costs. Such expenses have increased as a percentage
of revenues in the third quarter of fiscal 1997 as compared to the comparable
fiscal 1996 period, reflecting the recent decline in revenues. The timing
and extent of future legal costs associated with the ongoing enforcement
of the Company's intellectual property rights are not readily predictable
and may increase the level of future general and administrative expenses.
Operating Income
Operating income was $36.9 million, or 27.2% of revenues,
and $120.9 million, excluding the impact of the $5 million non-recurring
write-off relating to the XC8100 product family in the second quarter of
fiscal 1996, or 29% of revenues, for the third quarter of fiscal 1997 and
the first nine months of fiscal 1997, respectively. Operating income was
$49.3 million, or 34.2% of revenues, and $132.4 million (excluding the
impact of the $19.4 million write-off of in-process technology associated
with the acquisition of NeoCAD), or 32.2% of revenues, respectively, for
the comparable fiscal 1996 periods. Operating income decreased $12.4 million
during the third quarter of fiscal 1997 as compared to the comparable period
of the prior year. The decrease was primarily attributable to a decrease
in revenues achieved in the comparable three month periods. Operating income
decreased $11.6 million, excluding the impact of non-recurring write-offs,
during the first nine months of fiscal 1997 as compared to the comparable
period of the prior year. The decrease was primarily attributable to increased
expenses and minimal revenue growth.
Interest and other income, net
The Company incurs interest expense on the $250 million
of 5 1/4% convertible notes issued in November 1995. The Company earns
interest income on its cash, cash equivalents, short-term investments,
restricted investments and on the outstanding amount of the advances for
wafer purchases. The amount of interest earned is a function of the balance
of cash invested as well as the prevailing interest rates. The Company
also records 25% of United Silicon Inc.'s net income as joint venture equity
income. Net interest and other income was $1.9 million in the third quarter
of fiscal 1997 as compared to $1.4 million during the comparable prior
year period. The increase is primarily attributable to increased interest
income resulting from higher investment portfolio balances and joint venture
equity income. The Company's investment portfolio contains tax-advantaged
municipal bonds, which generally have pretax yields which are less than
the interest rate on the convertible notes. For financial reporting purposes,
the Company records the difference between the pretax and tax-equivalent
yields as a reduction in provision for taxes on income. As a result of
the difference in yields and future uses of the investment portfolio, levels
of net interest income could decrease in the future.
Provision for Income Taxes
The Company recorded a tax provision of $12.6 million
(32.5% of income before taxes) for the third quarter of fiscal 1997 and
a tax provision of $40.7 million (33.8% of income before taxes) for the
first nine months of fiscal 1997 as compared to a tax provision for the
third quarter of fiscal 1996 of $18.5 million (36.5% of income before taxes)
and a provision for taxes for the first nine months of fiscal 1996 of $50
million (42.5% of income before taxes). The higher tax rate for the first
nine months of fiscal 1996 resulted from the non-recurring write-off of
in-process technology which is not tax deductible. Excluding the non-recurring
write-off of in-process technology, the Company's effective tax rate for
the first nine months of fiscal 1996 was 36.5%. The reduced tax rate in
fiscal 1997 resulted from legislation reinstating the R&D Tax Credit
as well as an increase in foreign operations where tax rates are lower
than the U. S. effective tax rate.
Risk Factors
The following risk factors may be associated with the
Company's business:
Factors Affecting Future Operating Results
The semiconductor industry is characterized by rapid technological
change, intense competitive pressure and cyclical market patterns. The
Company's results of operations are affected by a wide variety of factors,
including general economic conditions and conditions specific to the semiconductor
industry, decreases in average selling price over the life of any particular
product, the timing and implementation of new product introductions (both
by the Company and its competitors), the timely implementation of new manufacturing
technologies, the ability to safeguard patents and intellectual property
in a rapidly evolving market, and rapid escalation of demand for some products
in the face of equally steep decline in demand for others. Market demand
for the Company's products, particularly for those most recently introduced,
can be difficult to predict, especially in light of customers' demands
to shorten product lead time and minimize inventory levels. This could
lead to revenue volatility if the Company were unable to provide sufficient
quantities of specified products in a given quarter. In addition, any difficulty
in achieving targeted yields could adversely impact the Company's results
of operations. The Company attempts to identify these changes in market
conditions as soon as possible; however, the rapidity of their onset makes
prediction of and reaction to such events difficult. Due to the foregoing
and other factors, past results, such as those described in this report,
are a much less useful predictor of the future than is the case in many
older, more stable and less dynamic industries.
The semiconductor industry has historically been cyclical
and subject to significant economic downturns at various times, characterized
by diminished product demand, accelerated erosion of average selling prices
and overcapacity. The Company may experience substantial period-to-period
fluctuations in future operating results due to general semiconductor industry
conditions, overall economic conditions or other factors.
Many of the Company's operations are centered in an area
that has been seismically active. Should there be a major earthquake in
this area, the Company's operations may be disrupted resulting in the inability
of the Company to ship products in a timely manner, thereby materially
adversely affecting the Company's business.
In addition, the securities of many high technology companies
have historically been subject to extreme price and volume fluctuations,
a factor which may adversely affect the market price of the Company's Common
Stock.
Dependence Upon Independent Manufacturers
The Company does not manufacture the wafers used for its
products. In fiscal 1997, most of the Company's wafers have been manufactured
by Seiko Epson Corporation (Seiko) and United Microelectronics Corporation
(UMC). The Company has depended upon these suppliers and others to produce
wafers with competitive performance and cost attributes and to deliver
them to the Company in a timely manner. While the timeliness, yield and
quality of wafer deliveries to date from these suppliers have been acceptable,
there can be no assurance that manufacturing problems will not occur in
the future. Any prolonged inability to obtain wafers with competitive performance
and cost attributes, adequate yields or timely deliveries from these manufacturers,
or any other circumstance that would require the Company to seek alternative
sources of supply, could delay shipments. Any significant delays could
have a material adverse effect on the Company's operating results. In addition,
the Company's purchases from Seiko are denominated in yen. In fiscal 1997
the US dollar has strengthened against the yen; however, prolonged periods
of a weakened US dollar exchange rate against the yen could adversely affect
manufacturing costs.
The Company's long-term growth will depend in large part
on the Company's ability to obtain increased wafer fabrication capacity
from suppliers. A significant increase in general industry demand or any
interruption of supply could reduce the Company's supply of wafers or increase
the Company's cost of such wafers, thereby materially adversely affecting
the Company's business.
In order to secure additional wafer capacity, the Company
from time to time considers a number of alternatives, including, without
limitation, equity investments in, or loans, deposits, or other financial
commitments to, independent wafer manufacturers in exchange for production
capacity, or the use of contracts which commit the Company to purchase
specified quantities of wafers over extended periods. Although the Company
is currently able to obtain wafers from existing suppliers in a timely
manner, the Company has at times been unable, and may in the future be
unable, to fully satisfy customer demand because of production constraints,
including the ability of suppliers and subcontractors to provide materials
and services in satisfaction of customer delivery dates, as well as the
ability of the Company to process products for shipment. The Company's
future growth will depend in part on its ability to locate and qualify
additional suppliers and subcontractors and to increase its own capacity
to ship products, and there can be no assurance that the Company will be
able to do so. Any increase in these constraints on the Company's production
could materially adversely affect the Company's business. In this regard,
the Company has entered into a joint venture, United Silicon Inc., with
UMC and other parties to obtain wafer capacity from a new wafer fabrication
facility. However, there are many risks associated with the construction
of a new facility, and there can be no assurance that such facility will
become operational in a timely manner. In addition, the Company's recent
agreement with Seiko was made to obtain additional capacity from a facility
currently under construction and expected to provide wafers in volume in
calendar 1998. If the Company requires additional capacity and such capacity
is unavailable, or unavailable on reasonable terms, the Company's business
could be materially adversely affected.
Dependence on New Products
The Company's future success depends on its ability to
develop and introduce on a timely basis new products which compete effectively
on the basis of price and performance and which address customer requirements.
The success of new product introductions is dependent upon several factors,
including timely completion of new product designs, the ability to utilize
advanced process technologies, achievement of acceptable yields and market
acceptance. No assurance can be given that the Company's product development
efforts will be successful or that its new products will achieve market
acceptance. Revenues relating to the Company's first generation FPGA products
are expected to decline in the future as a percentage of aggregate component
revenues and the Company will be increasingly dependent on revenues derived
from second generation FPGA's and other products. In addition, the average
selling price for any particular product tends to decrease rapidly over
the product's life. To offset such decreases, the Company relies primarily
on obtaining yield improvements and corresponding cost reductions in the
manufacture of existing products and on introducing new products which
incorporate advanced features and other price/performance factors such
that higher average selling prices and higher margins are achievable relative
to mature product lines. To the extent that such cost reductions and new
product introductions with higher margins do not occur in a timely manner
or the Company's products do not achieve market acceptance, the Company's
operating results could be adversely affected.
Competition
The Company's FPGA and CPLD products compete in the programmable
logic marketplace, with a substantial majority of the Company's revenues
derived from its FPGA product families. The industries in which the Company
competes are intensely competitive and are characterized by rapid technological
change, rapid product obsolescence and price erosion. The Company expects
significantly increased competition both from existing competitors and
from a number of companies that may enter its market. Xilinx believes that
important competitive factors in the programmable logic market include
price, product performance and reliability, adaptability of products to
specific applications, ease of use and functionality of development system
software, and technical service and support. The Company's strategy for
expansion in the programmable logic market includes continued price reductions
commensurate with the ability to lower the cost of manufacture and continued
introduction of new product architectures which target high volume, low
cost applications. However, there can be no assurance that the Company
will be successful in achieving this strategy.
The Company's major sources of competition are comprised
of three elements: the manufacturers of custom CMOS gate arrays, providers
of high density programmable logic products characterized by FPGA-type
architectures and other providers of programmable logic products. The Company
competes with custom gate array manufacturers on the basis of lower design
costs, shorter development schedules and reduced inventory risks. The primary
attributes of custom gate arrays are high density, high speed and low production
costs in high volumes. The Company is currently involved in developing
lower cost architectures which are intended to narrow the gap between current
custom gate array production costs (in high volumes) and FPGA production
costs. To the extent that such efforts are not successful, the Company's
business could be materially adversely affected.
The Company competes with providers of high density programmable
logic products characterized by FPGA-type architectures on the basis of
software capability, product functionality, price, performance and customer
service. The Company believes that certain of its patents have been infringed
by a competitor and has initiated legal action to protect its intellectual
property (see "Litigation").
The benefits of programmable logic have attracted a number
of companies to this market, competing primarily on the basis of speed,
density or cost. Xilinx recognizes that different applications require
different programmable technologies, and the Company is developing multiple
architectures, processes and products to meet these varying customer needs.
Recognizing the increasing importance of standard software solutions, Xilinx
is working to develop common design software that supports the full range
of integrated circuit products. Xilinx believes that automation and ease
of design will be significant competitive factors in the programmable logic
market.
Several companies, both large and small, have introduced products competitive with those of the Company or have announced their intention to enter this market. Some of the Company's competitors may possess innovative technology which could prove superior to Xilinx's technology in some applications. In addition, the Company anticipates potential competition from suppliers of logic products based on new technologies. Many of the Company's current or potential competitors have substantially greater financial, manufacturing, marketing and technical resources
than Xilinx. This additional competition could adversely
affect the Company Xilinx also faces competition from its licensees. Under
a license from the Company, Lucent Technologies is manufacturing and marketing
the Company's non-proprietary XC3000 products and is employing that technology
to provide additional FPGA products offering higher density. Seiko has
rights to manufacture the Company's products and market them in Japan and
Europe but is not currently doing so. Advanced Micro Devices is licensed
to use certain of the Company's patents to manufacture and market products
other than SRAM-based FPGAs and, after March 19, 1997, could also compete
directly in this market. Intellectual Property
The Company relies upon patent, trademark, trade secret
and copyright law to protect its intellectual property. There can be no
assurance that such intellectual property rights can be successfully asserted
in the future or will not be invalidated, circumvented or challenged. From
time to time, third parties, including competitors of the Company, may
assert exclusive patent, copyright and other intellectual property rights
to technologies that are important to the Company. There can be no assurance
that third parties will not assert infringement claims against the Company
in the future, that assertions by third parties will not result in costly
litigation or that the Company would prevail in such litigation or be able
to license any valid and infringed patents from third parties on commercially
reasonable terms. Litigation, regardless of its outcome, could result in
substantial cost and diversion of resources of the Company. Any infringement
claim or other litigation against or by the Company could materially adversely
affect the Company's financial condition and results of operations.
Litigation
The Company is currently engaged in patent litigation
with Altera Corporation (Altera). See ìLegal Proceedingsî
in Part II.
Financial Condition, Liquidity and Capital Resources
The Company's financial condition at December 28, 1996
remained strong. Total current assets exceeded total current liabilities
by 5.6 times, as compared to 5.2 times at March 30, 1996. Since its inception,
the Company has used a combination of equity and debt financing and internal
cash flow to support operations, obtain additional wafer supply capacity,
make acquisitions and investments in complementary technologies, obtain
additional capital equipment and facilities and finance inventory and accounts
receivable.
The Company has generated positive cash flow from operations
for the first nine months of fiscal 1997. As of December 28, 1996, the
Company had cash, cash equivalents and short-term investments of $390.1
million and working capital of $463.2 million as compared to $378 million
and $436.1 million, respectively, at March 30, 1996. Cash generated by
operations of $88.7 million for the first nine months of fiscal 1997 was
$19.3 million lower than the $108 million generated for the first nine
months of fiscal 1996. The decrease in cash generated by operations during
the first nine months of fiscal 1997 over the comparable fiscal 1996 period
resulted primarily from the unfavorable impact of the changes in inventory
and deferred income on shipments to distributors offset by the favorable
impact of the change in accounts receivable.
Cash flows used for investing activities for the nine months ended December 28, 1996, included $31.5 million of net short-term investment proceeds. Uses of cash included the $60 million advance to Seiko for wafer purchases (see Note 3 of Notes to Consolidated Condensed Financial Statements) and $22.3 million of property, plant and equipment acquisitions. Property, plant and equipment additions decreased $20.9 million from the comparable fiscal 1996 period. This decrease is primarily due to significantly reduced expenditures relating to the Company's Ireland manufacturing facility which were partially offset by expenditures incurred relating to the Company's facility being constructed in Boulder, Colorado. In the first nine months of fiscal 1996, the Company's investing activities included $33.4 million (net of cash acquired) incurred relating to the acquisition of NeoCAD and $23.5 million of net purchases of restricted investments relating to the Company's Corporate facilities. Additionally, the Company invested the majority of the $244.2 million net proceeds from the issuance of convertible notes in short-term investments.
Cash flows provided by financing activities were $6.2
million in the first nine months of fiscal 1997 and was attributable to
$22.7 million in proceeds from the issuance of common stock under employee
stock plans offset by acquisitions of treasury stock of $15.7 (see Note
5 of Notes to Consolidated Condensed Financial Statements). For the comparable
fiscal 1996 period, financing activities included $244.2 million in net
proceeds from the issuance of convertible notes and $11.7 million in proceeds
from issuance of common stock under corporate stock plans.
Stockholders' equity increased by $91.9 million, principally
as a result of the net income for the nine months ended December 28, 1996,
proceeds from the issuance of common stock under employee stock plans and
related tax benefits from stock options, offset by the $15.7 million in
Treasury Stock purchased during the period.
The Company has available credit line facilities for up
to $47 million of which $7 million is intended to meet occasional working
capital requirements for the Company's wholly owned Irish subsidiary. At
December 28, 1996, no borrowings were outstanding under the lines of credit.
Under the terms of the Company's agreement relating to
the United Silicon Inc. (USI) joint venture, the Company expected to invest
additional amounts in installments of approximately $68 million and $34
million. The USI joint venture is accounted for by the equity method, as
the Company records 25% of USI's net income as joint venture equity income.
The Board of Directors of USI recently voted to postpone the wafer fabrication
facility construction schedule by approximately six months. As a result,
the additional payments are also postponed. The revised timing of construction
of the facility and the related payments are subject to further change
based on overall industry conditions and other factors. United Microelectronics
Corporation has committed to and is supplying the Company with wafers manufactured
in an existing facility until capacity is available in the new facility.
In the first quarter of fiscal 1997, the Company entered
into a wafer foundry/supply agreement with Seiko. The agreement provides
for total payments of $300 million to be made to Seiko, of which $200 million
is in the form of advance payments and $100 million is in the form of an
advance or an alternate form to be negotiated at a later date. Repayment
of the advances will be in the form of wafer deliveries, which are expected
to begin in the first half of calendar 1998, using dollar denominated pricing.
The advance payment provision also provides for interest to be paid to
the Company in the form of free wafers. See Note 3 of Notes to Consolidated
Condensed Financial Statements.
The Company anticipates that existing sources of liquidity
and cash flow from operations will be sufficient to satisfy the Company's
cash needs for the foreseeable future. The Company will continue to evaluate
opportunities for investments to obtain additional wafer supply capacity,
procurement of additional capital equipment and facilities, development
of new products, and potential acquisitions of businesses, products or
technologies that would complement the Company's businesses and may use
available cash or other sources of funding for such purposes. Part II.
Other Information
Item 1. Legal Proceedings.
On June 7, 1993, the Company filed suit against Altera
Corporation (Altera) in the United States District Court for the Northern
District of California for infringement of certain of the Company's patents.
Subsequently, Altera filed suit against the Company, alleging that certain
of the Company's products infringe certain Altera patents. Fact discovery
has been completed in both cases. Both cases have been consolidated and
assigned to Judge Spencer Williams. The cases are currently scheduled for
trial on September 15, 1997. On April 20, 1995, Altera filed an additional
suit against the Company in Federal District Court in Delaware, alleging
that the Company's XC5000 family infringes a certain Altera patent. The
Company answered that suit, denying that the XC5000 family infringes the
patent in suit, asserting certain affirmative defenses and counterclaiming
that the Altera Max 9000 family infringes certain of the Company's patents.
That suit has now been transferred to the United States District Court
for the Northern District of California and is also before Judge Spencer
Williams. Management believes that it has meritorious defenses to Altera's
claims and is defending them vigorously. The foregoing is a forward looking
statement based on information presently known to management. Due to the
uncertain nature of the litigation with Altera and because the lawsuits
are still in the pre-trial stage, actual results could differ materially.
There are no other pending legal proceedings of a material
nature to which the Company is a party or of which any of its property
is the subject. The Company knows of no legal proceedings contemplated
by any governmental authority or agency.
Item 6. Exhibits and Reports on Form 8-K.
(a) Exhibit 11: Statement of Computation of Net Income Per Share
Exhibit 12: Statement of Computation of Ratio of Earning
to Fixed Charges
(b) Reports on Form 8-K - None
SIGNATURES
Pursuant to the requirements of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on
its behalf by the undersigned thereunto duly authorized.
XILINX, INC.
Date February 10, 1997 /s/ Gordon M. Steel
Gordon M. Steel
Senior Vice President of Finance and
Chief Financial Officer
(as principal accounting and financial
officer and on behalf of Registrant)
EXHIBIT 11
XILINX, INC.
STATEMENT OF COMPUTATION OF NET INCOME PER SHARE
(in thousands, except per share amounts)
Three Months Ended Nine Months Ended
Dec. 28, Dec. 30, Dec. 28, Dec. 30
1996 |
1995 |
1996 |
1995 |
|
Primary | ||||
Weighted average number of
common shares outstanding |
72,931 |
71,117 |
72,653 |
70,845 |
Incremental common shares
attributable to outstanding options |
6,860 |
7,989 |
6,718 |
7,887 |
Total shares | 79,791 | 79,106 | 79,371 | 78,732 |
Net income | $ 26,223 | $ 32,190 | $ 79,933 | $ 67,564 |
Net income per share | $ 0.33 | $ 0.41 | $ 1.01 | $ 0.86 |
Fully Diluted | ||||
Weighted average number of
common shares outstanding |
72,931 |
71,117 |
72,653 |
70,845 |
Incremental common shares
attributable to outstanding options |
6,860 |
7,989 |
6,834 |
8,265 |
Total shares | 79,791 | 79,106 | 79,487 | 79,110 |
Net income | $ 26,223 | $ 32,190 | $ 79,933 | $ 67,564 |
Net income per share | $ 0.33 | $ 0.41 | $ 1.01 | $ 0.85 |
NOTE: The convertible debt is not included in the calculation of fully
diluted net income per share since their inclusion would have had an anti-dilutive
effect.
EXHIBIT 12
XILINX, INC.
STATEMENT OF COMPUTATION OF RATIOS OF EARNINGS TO FIXED CHARGES
(in thousands, except ratios)
Three Months Ended Nine Months Ended
Dec. 28, Dec. 30 Dec. 28 Dec. 30
1996 |
1995 |
1996 |
1995 |
|
Income before taxes | $ 38,849 | $ 50,693 | $ 120,658 | $ 117,532 |
Add fixed charges | 3,614 | 2,083 | 10,868 | 2,608 |
Earnings (as defined) | $ 42,463 | $ 52,776 | $ 131,526 | $ 120,140 |
Fixed charges | ||||
Interest expense | $ 3,184 | $ 1,775 | $ 9,655 | $ 1,938 |
Amortization of debt issuance costs | 223 | 138 | 664 | 138 |
Estimated interest component of rent expenses | 207 | 170 | 549 | 532 |
Total fixed charges | $ 3,614 | $ 2,083 | $ 10,868 | $ 2,608 |
Ratio of earnings to fixed charges | 11.7 | 25.3 | 12.1 | 46.1 |